BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34593902)

  • 21. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
    Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
    Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CaMKII Mediates TGFβ1-Induced Fibroblasts Activation and Its Cross Talk with Colon Cancer Cells.
    Chen W; Chen Y; Su J; Kang J; Ding Y; Ai W; Zhang J; Luo H; An P
    Dig Dis Sci; 2022 Jan; 67(1):134-145. PubMed ID: 33528688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiling the MicroRNA Payload of Exosomes Derived from Ex Vivo Primary Colorectal Fibroblasts.
    Bhome R; Goh R; Pickard K; Mellone M; Sayan AE; Mirnezami A
    Methods Mol Biol; 2017; 1509():115-122. PubMed ID: 27826922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
    Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
    J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
    Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1.
    Shang A; Wang X; Gu C; Liu W; Sun J; Zeng B; Chen C; Ji P; Wu J; Quan W; Yao Y; Wang W; Sun Z; Li D
    Aging (Albany NY); 2020 May; 12(9):8352-8371. PubMed ID: 32364530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.
    He X; Dong Y; Wu CW; Zhao Z; Ng SS; Chan FK; Sung JJ; Yu J
    Mol Med; 2013 Feb; 18(1):1491-8. PubMed ID: 23255074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
    Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
    Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
    Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
    Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pro-Inflammatory Microenvironment Modulates the Transfer of Mutated TP53 Mediated by Tumor Exosomes.
    Domenis R; Cifù A; Mio C; Fabris M; Curcio F
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-150-5p represses TP53 tumor suppressor gene to promote proliferation of colon adenocarcinoma.
    Liu F; Di Wang X
    Sci Rep; 2019 May; 9(1):6740. PubMed ID: 31043658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis.
    Ju Q; Zhao L; Gao J; Zhou L; Xu Y; Sun Y; Zhao X
    Chin J Cancer Res; 2019 Jun; 31(3):533-546. PubMed ID: 31354222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of exosome release and its prognostic value in human colorectal cancer.
    Silva J; Garcia V; Rodriguez M; Compte M; Cisneros E; Veguillas P; Garcia JM; Dominguez G; Campos-Martin Y; Cuevas J; Peña C; Herrera M; Diaz R; Mohammed N; Bonilla F
    Genes Chromosomes Cancer; 2012 Apr; 51(4):409-18. PubMed ID: 22420032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy.
    Sui X; Kong N; Wang X; Fang Y; Hu X; Xu Y; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan H; Han W
    Sci Rep; 2014 Apr; 4():4694. PubMed ID: 24733045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53.
    Fan K; Spassova I; Gravemeyer J; Ritter C; Horny K; Lange A; Gambichler T; Ødum N; Schrama D; Schadendorf D; Ugurel S; Becker JC
    Oncogene; 2021 Feb; 40(5):980-996. PubMed ID: 33311552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts.
    Wang J; Guan X; Zhang Y; Ge S; Zhang L; Li H; Wang X; Liu R; Ning T; Deng T; Zhang H; Jiang X; Ba Y; Huang D
    Cell Physiol Biochem; 2018; 49(3):869-883. PubMed ID: 30184548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis.
    Li BL; Lu W; Qu JJ; Ye L; Du GQ; Wan XP
    J Cell Physiol; 2019 Mar; 234(3):2943-2953. PubMed ID: 30146796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression.
    Wang X; Qin X; Yan M; Shi J; Xu Q; Li Z; Yang W; Zhang J; Chen W
    J Exp Clin Cancer Res; 2019 Apr; 38(1):151. PubMed ID: 30961650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-4435 is an UQCRB-related circulating miRNA in human colorectal cancer.
    Hong JW; Kim JM; Kim JE; Cho H; Kim D; Kim W; Oh JW; Kwon HJ
    Sci Rep; 2020 Feb; 10(1):2833. PubMed ID: 32071343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients.
    Herrera M; Berral-González A; López-Cade I; Galindo-Pumariño C; Bueno-Fortes S; Martín-Merino M; Carrato A; Ocaña A; De La Pinta C; López-Alfonso A; Peña C; García-Barberán V; De Las Rivas J
    Mol Cancer; 2021 Apr; 20(1):73. PubMed ID: 33926453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.